PO-0754: Safe inhomogeneus RT dose escalation in locally advanced NSCLC, -interim results from NARLAL2. (April 2018) - Schytte, T.; Nielsen, T.; Moeller, D.; Hoffmann, L.; Khalil, A.; Knap, M.; Lund, M.; Nyhus, C.; Hansen, T.; Ottosson, W.; Borissova, S.; Appelt, A.; et al.